Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Danimer Scientific
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of sustainably produced, renewable products including Nodax PHA

Founded in 2004
Founded in

Company type Public Public (DNMR)
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Bainbridge, GA Bainbridge, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Cleantech Group on 03/30/2023

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
10/04/2023
Chevron Phillips Chemical Company Chevron Phillips Chemical Company
Expand existing collaboration to include application development for Rinnovo™ polymers. Rinnovo™ is a type of polyhydroxyalkanoate (“PHA”) synthesized from lactones produced using Danimer’s proprietary Novo22™ catalyst technology, which can be used in the production of biodegradable alternatives to traditional plastics.
View source    
Confirmed by Chevron Phillips Chemical Company
Development Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

12/29/2020

IPO status

Listed

IPO Type

SPAC

Amount

$385M

Initial shares

Ticker symbol

DNMR

Exchange listed

New York Stock Exchange

Prospectus URL

Prospectus

Source URL

Source

Description

Danimer Scientific has become a publicly traded company through a merger with Live Oak Acquisition Corp. The combined firm will operate as Danimer Scientific. The Live Oak deal includes $890 million in equity and $385 million in cash.

Cancel Save
Add Investment
Date Investors Type Amount
03/20/2023 Jefferies Group Jefferies Group (1)
Post-money valuation of
These funds will be used to expand its capital structure and maintain strategic and operational flexibility as it executes its growth strategy.
 Loan $130,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font